Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Currently, the monitoring of children receiving a kidney transplantation includes surveillance biopsies to detect subclinical rejection and signs of toxicity of immunosuppressive drugs (tacrolimus). The hypothesis of the study is that the combination of non-invasive biomarkers (Donor-derived cell-free DNA and Virus-specific T cells) will allow both the safe discontinuation of surveillance biopsies and the personalization of the exposure to calcineurin inhibitors among pediatric kidney transplant recipients.
Key Details
Gender
All
Age Range
1 Year - 21 Years
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2025-03-01
Completion Date
2029-03-01
Last Updated
2025-01-07
Healthy Volunteers
No
Interventions
monitoring by dd-cfDNA
monitoring by dd-cfDNA
monitoring by T-Vis
monitoring by T-Vis
monitoring by dd-cfDNA+ T-Vis
monitoring by dd-cfDNA+ T-Vis
Locations (1)
Robert Debré Hospital
Paris, France